Hepatitis: Difference between revisions
Citation bot (talk | contribs) m Citation maintenance. Added: year. Formatted: doi. You can use this bot yourself! Please report any bugs. |
+-broken link |
||
Line 134: | Line 134: | ||
=== Metabolic disorders === |
=== Metabolic disorders === |
||
Some metabolic disorders cause different forms of hepatitis. [[Hemochromatosis]] (due to [[iron]] accumulation) and [[Wilson's disease]] ([[copper]] accumulation) can cause |
Some metabolic disorders cause different forms of hepatitis. [[Hemochromatosis]] (due to [[iron]] accumulation) and [[Wilson's disease]] ([[copper]] accumulation) can cause liver inflammation and [[necrosis]]. |
||
[[Non-alcoholic steatohepatitis]] (NASH) is effectively a consequence of [[metabolic syndrome]]. |
[[Non-alcoholic steatohepatitis]] (NASH) is effectively a consequence of [[metabolic syndrome]]. |
||
Line 146: | Line 146: | ||
{{main|Autoimmune hepatitis}} |
{{main|Autoimmune hepatitis}} |
||
Anomalous presentation of [[human leukocyte antigen]] (HLA) class II on the surface of [[hepatocyte]]s, possibly due to [[gene]]tic predisposition or |
Anomalous presentation of [[human leukocyte antigen]] (HLA) class II on the surface of [[hepatocyte]]s, possibly due to [[gene]]tic predisposition or acute liver infection; causes a cell-mediated [[immune response]] against the body's own liver, resulting in [[autoimmune hepatitis]]. |
||
=== Alpha 1-antitrypsin deficiency === |
=== Alpha 1-antitrypsin deficiency === |
||
Line 178: | Line 178: | ||
{{refbegin}} |
{{refbegin}} |
||
* [http://www.who.int/topics/hepatitis/en/ WHO fact sheet of hepatitis] |
* [http://www.who.int/topics/hepatitis/en/ WHO fact sheet of hepatitis] |
||
* [http:// |
* Slides- [http://pn.lifehugger.com/doc/374/hepatitis Hepatitis] [http://pn.lifehugger.com/doc/520/hepatitis-b-overview-management , Hepatitis B Management] |
||
* [http://www.cdc.gov/ncidod/diseases/hepatitis/ Viral Hepatitis at the Centers for Disease Control] |
* [http://www.cdc.gov/ncidod/diseases/hepatitis/ Viral Hepatitis at the Centers for Disease Control] |
||
Revision as of 06:35, 12 April 2009
Hepatitis | |
---|---|
Specialty | Gastroenterology, hepatology, infectious diseases, internal medicine, family medicine |
Hepatitis (plural hepatitides) implies injury to the liver characterized by the presence of inflammatory cells in the tissue of the organ. The name is from ancient Greek hepar (ηπαρ), the root being hepat- (ηπατ-), meaning liver, and suffix -itis, meaning "inflammation" (c. 1727)[1]. The condition can be self-limiting, healing on its own, or can progress to scarring of the liver. Hepatitis is acute when it lasts less than six months and chronic when it persists longer. A group of viruses known as the hepatitis viruses cause most cases of liver damage worldwide. Hepatitis can also be due to toxins (notably alcohol), other infections or from autoimmune process. It may run a subclinical course when the affected person may not feel ill. The patient becomes unwell and symptomatic when the disease impairs liver functions that include, among other things, removal of harmful substances, regulation of blood composition, and production of bile to help digestion.
Causes
Acute
- Viral hepatitis: Hepatitis A through E (more than 95% of viral cause), Herpes simplex, Cytomegalovirus, Epstein-Barr, yellow fever virus, adenoviruses.
- Non viral infection: toxoplasma, Leptospira, Q fever,[2] rocky mountain spotted fever[3]
- Alcohol
- Toxins: Amanita toxin in mushrooms, carbon tetrachloride, asafetida
- Drugs: Paracetamol, amoxycillin, antituberculosis medicines, minocycline and many others (see longer list below).
- Ischemic hepatitis (circulatory insufficiency)
- Pregnancy
- Auto immune conditions, e.g. Systemic Lupus Erythematosus (SLE)
- Metabolic diseases, e.g. Wilson's disease
Chronic
- Viral hepatitis: Hepatitis B with or without hepatitis D, hepatitis C (neither hepatitis A nor hepatitis E causes chronic hepatitis)
- Autoimmune: Autoimmune hepatitis
- Alcohol
- Drugs: methyldopa, nitrofurantoin, isoniazid, ketoconazole
- Non-alcoholic steatohepatitis
- Heredity: Wilson's disease, alpha 1-antitrypsin deficiency
- Primary biliary cirrhosis and primary sclerosing cholangitis occasionally mimic chronic hepatitis[4]
Symptoms
Acute
Clinically, the course of acute hepatitis varies widely from mild symptoms requiring no treatment to fulminant hepatic failure needing liver transplantation. Acute viral hepatitis is more likely to be asymptomatic in younger people. Symptomatic individuals may present after convalescent stage of 7 to 10 days, with the total illness lasting 2 to 6 weeks.[4]
Initial features are of nonspecific flu-like symptoms, common to almost all acute viral infections and may include malaise, muscle and joint aches, fever, nausea or vomiting, diarrhea, and headache. More specific symptoms, which can be present in acute hepatitis from any cause, are: profound loss of appetite, aversion to smoking among smokers, dark urine, yellowing of the eyes and skin (i.e., jaundice) and abdominal discomfort. Physical findings are usually minimal, apart from jaundice (33%) and tender hepatomegaly (10%). There can be occasional lymphadenopathy (5%) or splenomegaly (5%).[5]
Chronic
Majority of patients will remain asymptomatic or mildly symptomatic, abnormal blood tests being the only manifestation. Features may be related to the extent of liver damage or the cause of hepatitis. Many experience return of symptoms related to acute hepatitis. Jaundice can be a late feature and may indicate extensive damage. Other features include abdominal fullness from enlarged liver or spleen, low grade fever and fluid retention (ascites). Extensive damage and scarring of liver (i.e., cirrhosis) leads to weight loss, easy bruising and bleeding tendencies. Acne, abnormal menstruation, lung scarring, inflammation of the thyroid gland and kidneys may be present in women with autoimmune hepatitis.[6]
Findings on clinical examination are usually those of cirrhosis or are related to aetiology.
Types
Viral
Most cases of acute hepatitis are due to viral infections:
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis B with D
- Hepatitis E
- Hepatitis F virus (existence unknown)
- Hepatitis G, or GBV-C
- In addition to the hepatitis viruses (please note that the hepatitis viruses are not all related), other viruses can also cause hepatitis, including cytomegalovirus, Epstein-Barr virus, yellow fever, etc.
Other viral causes
Other viral infections can cause hepatitis (inflammation of the liver):
Alcoholic hepatitis
Ethanol, mostly in alcoholic beverages, is a significant cause of hepatitis. Usually alcoholic hepatitis comes after a period of increased alcohol consumption. Alcoholic hepatitis is characterized by a variable constellation of symptoms, which may include feeling unwell, enlargement of the liver, development of fluid in the abdomen ascites, and modest elevation of liver blood tests. Alcoholic hepatitis can vary from mild with only liver test elevation to severe liver inflammation with development of jaundice, prolonged prothrombin time, and liver failure. Severe cases are characterized by either obtundation (dulled consciousness) or the combination of elevated bilirubin levels and prolonged prothrombin time; the mortality rate in both categories is 50% within 30 days of onset.
Alcoholic hepatitis is distinct from cirrhosis caused by long term alcohol consumption. Alcoholic hepatitis can occur in patients with chronic alcoholic liver disease and alcoholic cirrhosis. Alcoholic hepatitis by itself does not lead to cirrhosis, but cirrhosis is more common in patients with long term alcohol consumption. Patients who drink alcohol to excess are also more often than others found to have hepatitis C.[citation needed] The combination of hepatitis C and alcohol consumption accelerates the development of cirrhosis.
Drug induced
A large number of drugs can cause hepatitis:[7]
- Allopurinol
- Amitriptyline (antidepressant)
- Amiodarone (antiarrhythmic)
- Atomoxetine [8]
- Azathioprine[9]
- Halothane (a specific type of anesthetic gas)
- Hormonal contraceptives
- Ibuprofen and indomethacin (NSAIDs)
- Isoniazid (INH), rifampicin, and pyrazinamide (tuberculosis-specific antibiotics)
- Ketoconazole (antifungal)
- Loratadine (antihistamine)
- Methotrexate (immune suppressant)
- Methyldopa (antihypertensive)
- Minocycline (tetracycline antibiotic)
- Nifedipine (antihypertensive)
- Nitrofurantoin (antibiotic)
- Paracetamol (acetaminophen in the United States) can cause hepatitis when taken in an overdose. The severity of liver damage may be limited by prompt administration of acetylcysteine.
- Phenytoin and valproic acid (antiepileptics)
- Troglitazone (antidiabetic, withdrawn in 2000 for causing hepatitis)
- Zidovudine (antiretroviral i.e. against HIV)
- Some herbs and nutritional supplements[10]
The clinical course of drug-induced hepatitis is quite variable, depending on the drug and the patient's tendency to react to the drug. For example, halothane hepatitis can range from mild to fatal as can INH-induced hepatitis. Hormonal contraception can cause structural changes in the liver. Amiodarone hepatitis can be untreatable since the long half life of the drug (up to 60 days) means that there is no effective way to stop exposure to the drug. Statins can cause elevations of liver function blood tests normally without indicating an underlying hepatitis. Lastly, human variability is such that any drug can be a cause of hepatitis.
Other toxins
Other Toxins can cause hepatitis:
- Amatoxin-containing mushrooms, including the Death Cap (Amanita phalloides), the Destroying Angel (Amanita ocreata), and some species of Galerina. A portion of a single mushroom can be enough to be lethal (10 mg or less of α-amanitin).
- White phosphorus, an industrial toxin and war chemical.
- Carbon tetrachloride ("tetra", a dry cleaning agent), chloroform, and trichloroethylene, all chlorinated hydrocarbons, cause steatohepatitis (hepatitis with fatty liver).
- Cylindrospermopsin, a toxin from the cyanobacterium Cylindrospermopsis raciborskii and other cyanobacteria.
Metabolic disorders
Some metabolic disorders cause different forms of hepatitis. Hemochromatosis (due to iron accumulation) and Wilson's disease (copper accumulation) can cause liver inflammation and necrosis.
Non-alcoholic steatohepatitis (NASH) is effectively a consequence of metabolic syndrome.
Obstructive
"Obstructive jaundice" is the term used to describe jaundice due to obstruction of the bile duct (by gallstones or external obstruction by cancer). If longstanding, it leads to destruction and inflammation of liver tissue.
Autoimmune
Anomalous presentation of human leukocyte antigen (HLA) class II on the surface of hepatocytes, possibly due to genetic predisposition or acute liver infection; causes a cell-mediated immune response against the body's own liver, resulting in autoimmune hepatitis.
Alpha 1-antitrypsin deficiency
In severe cases of alpha 1-antitrypsin deficiency (A1AD), the accumulated protein in the endoplasmic reticulum causes liver cell damage and inflammation.
Non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the occurrence of fatty liver in people who have no history of alcohol use. It is most commonly associated with obesity (80% of all obese people have fatty liver). It is more common in women. Severe NAFLD leads to inflammation, a state referred to as non-alcoholic steatohepatitis (NASH), which on biopsy of the liver resembles alcoholic hepatitis (with fat droplets and inflammatory cells, but usually no Mallory bodies).
The diagnosis depends on medical history, physical exam, blood tests, radiological imaging and sometimes a liver biopsy. The initial evaluation to identify the presence of fatty infiltration of the liver is medical imaging, including such ultrasound, computed tomography (CT), or magnetic resonance (MRI). However, imaging cannot readily identify inflammation in the liver. Therefore, the differentiation between steatosis and NASH often requires a liver biopsy. It can also be difficult to distinguish NASH from alcoholic hepatitis when the patient has a history of alcohol consumption. Sometimes in such cases a trial of abstinence from alcohol along with follow-up blood tests and a repeated liver biopsy are required.
NASH is becoming recognized as the most important cause of liver disease second only to hepatitis C in numbers of patients going on to cirrhosis.[citation needed]
Ischemic hepatitis
Ischemic hepatitis is caused by decreased circulation to the liver cells. Usually this is due to decreased blood pressure (or shock), leading to the equivalent term "shock liver". Patients with ischemic hepatitis are usually very ill due to the underlying cause of shock. Rarely, ischemic hepatitis can be caused by local problems with the blood vessels that supply oxygen to the liver (such as thrombosis, or clotting of the hepatic artery which partially supplies blood to liver cells). Blood testing of a person with ischemic hepatitis will show very high levels of transaminase enzymes (AST and ALT), which may exceed 1000 U/L. The elevation in these blood tests is usually transient (lasting 7 to 10 days). It is rare that liver function will be affected by ischemic hepatitis.
See also
References
- ^ Online Etymology Dictionary [1]
- ^ Figure 7.12 (Some causes of acute parenchymal damage), Parveen, M.D. Kumar (Editor), Michael, M.d. Clark (Editor) (2005). Clinical Medicine: with STUDENT CONSULT Access. Philadelphia, PA: W.B. Saunders Company. ISBN 0-7020-2763-4.
{{cite book}}
:|author=
has generic name (help)CS1 maint: multiple names: authors list (link) - ^ Scott Moses, MD, Acute Hepatitis causes, Family practice notebook.com
- ^ a b V.G. Bain and M. Ma, Acute Viral Hepatitis, Chapter 14, First principle of gastroenterology (an online text book)
- ^ Ryder S, Beckingham I (2001). "ABC of diseases of liver, pancreas, and biliary system: Acute hepatitis". BMJ. 322 (7279): 151–153. doi:10.1136/bmj.322.7279.151. PMID 11159575.
- ^ Chronic hepatitis at Merck Manual of Diagnosis and Therapy Home Edition
- ^ "Hepatitis as a result of chemicals and drugs". HealthAtoZ. Retrieved 2006-07-01.
- ^ Lim JR, Faught PR, Chalasani NP, Molleston JP (2006). "Severe liver injury after initiating therapy with atomoxetine in two children". J. Pediatr. 148 (6): 831–4. doi:10.1016/j.jpeds.2006.01.035. PMID 16769398.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Bastida G, Nos P, Aguas M, Beltrán B, Rubín A, Dasí F, Ponce J (2005). "Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease". Aliment Pharmacol Ther. 22 (9): 775–82. doi:10.1111/j.1365-2036.2005.02636.x. PMID 16225485.
{{cite journal}}
: CS1 maint: multiple names: authors list (link) - ^ Nadir A, Reddy D, Van Thiel DH (2000). "Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity". Am. J. Gastroenterol. 95 (12): 3634–7. doi:10.1111/j.1572-0241.2000.03386.x. PMID 11151906.
{{cite journal}}
: CS1 maint: multiple names: authors list (link)